Edimara Rafaelli Balzer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Edimara Rafaelli Balzer has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Fatima Menegat Schuinski
State University of Ponta Grossa
2 shared publications - Bianca Drewnowski
Universidade Estadual de Ponta Grossa
2 shared publications - Gilberto Baroni
State University of Ponta Grossa
2 shared publications - José Carlos Rebuglio Vellosa
Universidade Estadual de Ponta Grossa
2 shared publications - Mariana Schechtel Koch
Universidade Estadual de Ponta Grossa
2 shared publications - Akel Azzi
Saint-Joseph University
1 shared publication
Latest Publications
- Open Access
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Avaliação preliminar da relação entre pressão arterial e pressão intracraniana em pacientes de diferentes estágios da doença renal crônica
Objetivo: Verificar se há perturbação da autorregulação da complacência intracraniana em pacientes com doença renal crônica (DRC), quando estes apresentam alteração de pressão arterial (PA). Metodologia: Foram realizadas monitorizações da pressão intracraniana (PIC) em pacientes renais crônicos por meio de um sensor não invasivo, desenvolvido pela empresa Brain4care®. Os dados dos pacientes monitorizados foram analisados estatisticamente e testou-se a correlação entre os parâmetros de PIC com pressão arterial (PA) e batimentos por minuto (BPM), correlação entre a filtração glomerular com PA e BPM, e comparação entre os grupos DRC em relação à PA, BPM e PIC. Resultados: Não se observou diferença entre os estágios da DRC, e não houve correlação entre a PIC (razão P2/P1 e TTP) e a PA. Entretanto, houve forte correlação entre as pressões sistólica (PAS) e diastólica (PAD) e os parâmetros da PIC. Conclusão: Como houve forte correlação entre as pressões sistólica e diastólica e os parâmetros da PIC, há indício de prejuízo na complacência intracraniana destes pacientes, evidenciando que o portador da DRC tem sua homeostasia prejudicada quando em presença HAS.
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Open AccessAvaliação preliminar da relação entre pressão arterial e pressão intracraniana em pacientes de diferentes estágios da doença renal crônica
Objetivo: Verificar se há perturbação da autorregulação da complacência intracraniana em pacientes com doença renal crônica (DRC), quando estes apresentam alteração de pressão arterial (PA). Metodologia: Foram realizadas monitorizações da pressão intracraniana (PIC) em pacientes renais crônicos por meio de um sensor não invasivo, desenvolvido pela empresa Brain4care®. Os dados dos pacientes monitorizados foram analisados estatisticamente e testou-se a correlação entre os parâmetros de PIC com pressão arterial (PA) e batimentos por minuto (BPM), correlação entre a filtração glomerular com PA e BPM, e comparação entre os grupos DRC em relação à PA, BPM e PIC. Resultados: Não se observou diferença entre os estágios da DRC, e não houve correlação entre a PIC (razão P2/P1 e TTP) e a PA. Entretanto, houve forte correlação entre as pressões sistólica (PAS) e diastólica (PAD) e os parâmetros da PIC. Conclusão: Como houve forte correlação entre as pressões sistólica e diastólica e os parâmetros da PIC, há indício de prejuízo na complacência intracraniana destes pacientes, evidenciando que o portador da DRC tem sua homeostasia prejudicada quando em presença HAS.
- Open Access
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Alteração da complacência intracraniana em paciente com doença renal crônica e diabetes mellitus T1: um relato de caso
Objective: The aim of this study was to relate the clinical profile with data on blood pressure (BP), intracranial pressure (ICP) and laboratory tests of a patient with Diabetes mellitus (DM) type 1 and chronic kidney disease (CKD) stage 5. Methodology: The research was carried out at the renal replacement therapy outpatient clinic of the Santa Casa de Misericórdia hospital, in Ponta Grossa-PR, previously approved by the ethics committee, under opinion nº 4,039,453. ICP monitoring and BP measurement were performed twice, on follow-up consultation days, in February and September 2020. In addition to the aforementioned parameters, a questionnaire on the patient's habits and demographic data was applied, and a consultation was carried out with the patient medical record for the collection of laboratory test data. Results: From February to September, the volunteer presented with persistent Systemic Arterial Hypertension (SAH) and hyperglycemia, and worsening of laboratory parameters. In February, the ICP morphology showed a significant change, suggesting intracranial hypertension, and the patient had a great impairment of visual acuity. In September, despite the worsening of the health condition, there was a significant improvement in vision and, also, an improvement in the ICP parameters, approaching normality. Between consultations, the diuretic administered by the patient was replaced. Conclusion: it is suggested that the visual impairment is due to intracranial hypertension and the improvement of both is related to the replacement of hydrochlorothiazide by furosemide, which occurred between consultations.
- 6 June 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (8)
Open AccessAlteração da complacência intracraniana em paciente com doença renal crônica e diabetes mellitus T1: um relato de caso
Objective: The aim of this study was to relate the clinical profile with data on blood pressure (BP), intracranial pressure (ICP) and laboratory tests of a patient with Diabetes mellitus (DM) type 1 and chronic kidney disease (CKD) stage 5. Methodology: The research was carried out at the renal replacement therapy outpatient clinic of the Santa Casa de Misericórdia hospital, in Ponta Grossa-PR, previously approved by the ethics committee, under opinion nº 4,039,453. ICP monitoring and BP measurement were performed twice, on follow-up consultation days, in February and September 2020. In addition to the aforementioned parameters, a questionnaire on the patient's habits and demographic data was applied, and a consultation was carried out with the patient medical record for the collection of laboratory test data. Results: From February to September, the volunteer presented with persistent Systemic Arterial Hypertension (SAH) and hyperglycemia, and worsening of laboratory parameters. In February, the ICP morphology showed a significant change, suggesting intracranial hypertension, and the patient had a great impairment of visual acuity. In September, despite the worsening of the health condition, there was a significant improvement in vision and, also, an improvement in the ICP parameters, approaching normality. Between consultations, the diuretic administered by the patient was replaced. Conclusion: it is suggested that the visual impairment is due to intracranial hypertension and the improvement of both is related to the replacement of hydrochlorothiazide by furosemide, which occurred between consultations.
- Open Access
- 1 October 1996
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 117 (2) , 401-403
Human parvovirus B19 infection within a family and risk for pregnant women
Summary: During an outbreak of parvovirus B19 infection among four related families at least 70% of the household contacts, including a woman at the 33rd week of pregnancy, became infected. Twins were born at the 39th week of pregnancy, both with B19 infection. B19 DNA was detected in their sera by a nested PCR, anti-B19 IgM was detectable only by an immunofluorescence assay, and low levels of maternal anti-B19 IgG were demonstrable by an immunoenzymatic test in the serum of both children. All the haematological parameters were normal at birth and 6 months later, when B19 DNA and anti-B19 antibody were no longer detectable in serum samples. This observation emphasizes the high risk of B19 infection among household contacts and the possibility of a favourable outcome of the foetal infection, possibly related to infection late in the pregnancy.
- 1 October 1996
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 117 (2) , 401-403
Open AccessHuman parvovirus B19 infection within a family and risk for pregnant women
Summary: During an outbreak of parvovirus B19 infection among four related families at least 70% of the household contacts, including a woman at the 33rd week of pregnancy, became infected. Twins were born at the 39th week of pregnancy, both with B19 infection. B19 DNA was detected in their sera by a nested PCR, anti-B19 IgM was detectable only by an immunofluorescence assay, and low levels of maternal anti-B19 IgG were demonstrable by an immunoenzymatic test in the serum of both children. All the haematological parameters were normal at birth and 6 months later, when B19 DNA and anti-B19 antibody were no longer detectable in serum samples. This observation emphasizes the high risk of B19 infection among household contacts and the possibility of a favourable outcome of the foetal infection, possibly related to infection late in the pregnancy.